Bologna, Italy

Giorgio Lenaz


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Giorgio Lenaz

Introduction

Giorgio Lenaz is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of ocular health and mitochondrial activity, holding a total of 2 patents. His work focuses on innovative treatments and diagnostic methods that have the potential to improve patient outcomes.

Latest Patents

One of Lenaz's latest patents is titled "Use of quinone Q10 for the treatment of ocular diseases." This invention relates to the use of Coenzyme Q or functionally equivalent derivatives for the prevention, treatment, and attenuation of degenerative ocular pathologies. These pathologies can be hereditary, inflammatory, dysmetabolic, or age-related, and the degenerative process is often linked to apoptotic events caused by hypoxia or other detrimental stimuli.

Another significant patent is "Method and kit for measuring mitochondrial activity." This invention describes a method for measuring mitochondrial activity by assessing platelet A lactate. It also introduces a new method for quantifying platelet lactate using the chromogenic agent 3-acetyl-pyridine-NAD and the ox heart LDH enzyme. Additionally, it includes a diagnostic micromethod kit for practical application.

Career Highlights

Throughout his career, Giorgio Lenaz has worked with various companies, including Giuseppe Simonelli. His innovative approaches and research have positioned him as a key figure in his field, contributing to advancements in medical technology and treatment methodologies.

Collaborations

Lenaz has collaborated with notable individuals such as Rosario Brancato and Sergio Capaccioli. These partnerships have further enriched his research and development efforts, leading to impactful innovations.

Conclusion

Giorgio Lenaz's contributions to the fields of ocular health and mitochondrial activity demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…